InvestorsHub Logo
Followers 21
Posts 1278
Boards Moderated 0
Alias Born 04/27/2020

Re: Grip it and Sip It post# 125782

Friday, 10/23/2020 10:35:08 AM

Friday, October 23, 2020 10:35:08 AM

Post# of 233240
Senior executive experience at Fortune 50 company is my background. I see this company staying focused on the goal line, at this time in getting approval for Covid and HIV.

In the company I worked we had many start ups that fought trends and existing businesses and some made the transition and some didn’t. One that I had extensive experience managing had a product that completely changed how things were done in that market. It took 4+ years to gain market presence, even though the product was far superior to the previous product. In the end our product garnered 94% market share in a 10 year period. If you have executive experience, as you indicate, then you would understand this process in bringing a product to market.

Not sure your intentions regarding Nader and the executive team. I know the hurdles they face and support them 100%. Reason: Leronlimab will impact many lives and have a positive effect whether a person lives or dies. DD has led me to this decision.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News